Loading institutional data...
Loading institutional data...
Held by 147 of 2,417 reporting institutions (93th percentile) — extremely crowded.
Data as of Q3 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading analysis...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading insider activity...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Solve the discounted cash flow backwards, then stress-test the assumptions.
The same 3 years as the 3-yr average, with the stock compensation of those years charged as a cost. Shares issued to employees are real dilution, so this asks what the business generates for existing holders.
To be worth $297.59 today, the market must believe free cash flow compounds 21.0%/yr for a decade (off $272.7M on the SBC-adjusted basis).
On the basis ($859.5M) the requirement is 4.4%/yr. The difference is what charging stock compensation costs.
The market's 21.0% is more optimistic than its 9-yr track record.
Default is 12.5% — this company's computed cost of capital (computed WACC), the same rate the Analysis tab discounts at.
2-stage DCF · 0.04B shares (market data) · net debt -$1.43B
mean 58.4% · volatility σ 275% · implied rate exceeded in 5/8 yrs
Central path = implied 21.0%/yr growth; shaded band = ±1σ (275%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
Ranked against 24 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-09-30.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BX | $90.5B | 31.2× | — | 6.3× | 9.2% | — | 20.9% | 34.8% | 14.2% | — | 721 |
| APO | $70.0B | 21.4× | — | 2.2× | 22.7% | — | 10.9% | 15.0% | 9.5% | — | — |
| AMP | $44.0B | 13.7× | — | 2.3× | 5.5% | — | 18.8% | 54.4% | 54.4% | — | 444 |
| TROW | $22.7B | 11.5× | — | 3.1× | 3.1% | — | 28.5% | 19.2% | 19.2% | — | 372 |
| BEN | $16.4B | 35.5× | 25.8× | 1.9× | 3.5% | — | 6.0% | 4.3% | 3.6% | 3.2× | 189 |
| CG | $14.5B | 18.6× | 9.2× | 3.0× | -11.9% | — | 16.9% | 11.5% | 11.5% | -1.5× | 146 |
| EVR | $11.4B | 21.2× | — | 3.0× | 29.5% | — | 15.3% | 29.1% | 29.1% | — | 147 |
| AMG | $10.3B | 17.6× | — | 5.0× | 1.6% | — | 34.5% | 22.1% | 12.1% | — | 131 |
| HLI | $9.7B | 22.4× | 15.0× | 3.7× | 9.5% | — | 16.3% | 18.2% | 18.2% | -2.1× | 125 |
| MORN | $8.3B | 25.1× | 12.5× | 3.4× | 7.5% | 61.0% | 15.3% | 30.6% | 16.3% | 0.8× | 92 |
| TPG | $8.0B | 106.5× | 12.3× | 1.7× | 33.4% | — | 4.0% | 4.5% | 3.2% | 1.2× | 67 |
| OWL | $7.1B | 104.1× | 21.4× | 12.5× | 7.6% | — | 13.9% | 3.6% | 1.4% | 6.5× | 138 |
| VCTR | $7.0B | 27.9× | 14.2× | 5.4× | 46.2% | — | 25.3% | 13.6% | 9.7% | 1.5× | 88 |
| FHI | $4.3B | 11.3× | 7.8× | 2.4× | 10.3% | — | 22.4% | 33.7% | 26.1% | -0.5× | 96 |
| LAZ | $3.9B | 18.2× | 11.3× | 1.2× | 1.5% | — | 7.4% | 27.2% | 9.3% | 0.6× | 77 |
| CNS | $3.7B | 24.6× | 19.2× | 6.7× | 7.5% | — | 27.6% | 27.3% | 27.3% | -0.8× | 65 |
| APAM | $2.6B | 9.0× | 6.8× | 2.2× | 7.6% | — | 24.3% | 66.2% | 46.2% | 0.5× | 79 |
| RPC | $1.0B | 54.6× | 20.3× | 3.4× | 0.3% | — | 6.6% | 4.8% | 2.5% | 5.1× | — |
| ABX | $842M | 23.9× | 11.3× | 3.6× | 110% | 87.7% | 15.5% | 8.7% | 4.4% | 3.4× | 19 |
| VRTS | $828M | 6.3× | 5.2× | 1.0× | -6.0% | — | 15.9% | 14.6% | 10.3% | 1.7× | 40 |
| GCMG | $771M | 30.0× | 6.9× | 1.4× | 8.5% | — | 8.1% | 168% | 10.0% | 1.4× | 18 |
| NOAH | $473M | 30.0× | — | 1.3× | 4.8% | — | 21.4% | 5.7% | 5.7% | — | 9 |
| HKHC | $381M | 75.8× | 28.2× | 5.2× | 30.5% | — | 7.0% | 1.5% | 1.5% | -3.0× | — |
| WHG | $181M | 24.0× | 28.2× | 1.9× | 3.2% | — | 7.2% | 5.6% | 5.6% | -4.8× | 14 |
| RILY | $148M | 0.5× | 12.2× | 0.1× | 29.6% | 85.0% | 31.8% | -179% | 24.5% | 10.8× | 15 |
Peers = companies sharing EVR's sector (Investment Advice) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
What the company returns to shareholders — and whether it's covered by cash.
The dividend is comfortably covered — only 12% of free cash flow, leaving room to grow it and fund buybacks. Last year: $144.4M dividends + $0 buybacks = $144.4M returned on $1.18B FCF.
9 consecutive years of dividend increases · 12%/yr.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A cash-return story — far more went to shareholders than back into the business (mature, low-reinvestment).
Insufficient data. Current ROIC on all capital: 29%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Insufficient EBITDA/debt history.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Interest expense isn't separately reported — often netted into “other income (expense), net.”
Cash vs short-term debt unavailable.
Short-term / long-term split not separately reported.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Educational — not a recommendation.
EOD close · as of 2026-10-29
How a revenue dollar becomes profit — FY2025
Dividends and buybacks are cash paid out, shown here against the same year's profit for scale — not funded from it.
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.88B 100.0% | $3.00B 100.0% | $2.44B 100.0% | $2.78B 100.0% | $3.31B 100.0% | $2.29B 100.0% | $2.03B 100.0% | $2.08B 100.0% | $1.72B 100.0% | $1.46B 100.0% |
| Total Operating Expenses | $3.07B 79.0% | $2.45B 81.9% | $2.07B 84.6% | $2.07B 74.3% | $2.19B 66.1% | $1.74B 76.0% | $1.57B 77.4% | $1.52B 73.1% | $1.28B 74.0% | $1.18B 80.9% |
| Interest Expense | $24.3M 0.6% | $16.8M 0.6% | $16.7M 0.7% | $16.9M 0.6% | $17.6M 0.5% | $21.4M 0.9% | $20.1M 1.0% | $17.8M 0.9% | $20.0M 1.2% | $16.7M 1.1% |
| Pretax Income | $793.8M 20.5% | $533.1M 17.8% | $365.8M 15.0% | $704.0M 25.3% | $1.12B 33.8% | $540.8M 23.7% | $448.7M 22.1% | $551.4M 26.5% | $437.6M 25.4% | $267.8M 18.4% |
| Income Tax Expense | $153.1M 3.9% | $115.4M 3.9% | $80.6M 3.3% | $172.6M 6.2% | $248.0M 7.5% | $128.2M 5.6% | $95.0M 4.7% | $108.5M 5.2% | $258.4M 15.0% | $119.3M 8.2% |
| Net Income | $592.0M 15.3% | $378.0M 12.6% | $255.0M 10.4% | $477.0M 17.2% | $740.0M 22.4% | $350.6M 15.3% | $297.4M 14.7% | $377.2M 18.1% | $125.5M 7.3% | $107.5M 7.4% |
| Per Share | ||||||||||
| EPS (Basic) | $15.29 | $9.86 | $6.71 | $12.15 | $18.48 | $8.64 | $7.44 | $9.29 | $3.16 | $2.74 |
| EPS (Diluted) | $14.05 | $9.08 | $6.37 | $11.61 | $17.08 | $8.22 | $6.89 | $8.33 | $2.80 | $2.43 |
| Weighted Avg Shares (Basic) | 38.7M | 38.4M | 38.1M | 39.2M | 40.1M | 40.6M | 40.0M | 40.6M | 39.6M | 39.2M |
| Weighted Avg Shares (Diluted) | 42.1M | 41.6M | 40.1M | 41.0M | 43.3M | 42.6M | 43.2M | 45.3M | 44.8M | 44.2M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
Last reported position per insider, carried forward. Steps can be a holding disclosed for the first time rather than a trade.
| Date | Insider | What it was | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-06-11 | Lalonde Timothy Gilbert Chief Financial Officer | Open-market sale | 7,808 | $343.06 | $2.7m |
| 2026-06-10 | Williamson Sarah K Director | Grant | 727 | $0.00 | $0 |
| 2026-06-10 | Wheeler William J Director | Grant | 364 | $0.00 | $0 |
| 2026-06-10 | Varney Christine A Director | Grant | 727 | $0.00 | $0 |
| 2026-06-10 |
Every row is classified by what it MEANT, not by its SEC code. A code is not a meaning: code P (“purchase”) also covers dividend reinvestment and employee stock purchase plans, and code S (“sale”) also covers 10b5-1 plan sales scheduled months earlier and option exercises sold the same day.
Across 30 days of all filings, $5.08bn of insider selling contained $3.50bn of plan sales and $0.46bn of exercise-and-sell. Only 29% was discretionary. Reading an unclassified feed badly overstates how much insiders decided.
Buys and sales are counted separately and never netted. They are different decisions by different people; a company where one officer bought while another sold is not “neutral”.
The holding line carries each insider's last reported position forward, so it shows the total held rather than a sawtooth of whoever traded that day. It covers only insiders who filed in the window.
“Filed late” counts calendar days past the two-business-day deadline with five days' grace, so a Thursday or Friday trade crossing a weekend is never flagged. It describes the company's filing discipline, not the trade.
Insider activity is descriptive. Nothing here is investment advice.
| Grant |
| 364 |
| $0.00 |
| $0 |
| 2026-06-10 | Overlock Wilard J Jr Director | Grant | 727 | $0.00 | $0 |
| 2026-06-10 | Millard Robert B Director | Grant | 815 | $0.00 | $0 |
| 2026-06-10 | Harris Gail Block Director | Grant | 364 | $0.00 | $0 |
| 2026-06-10 | Futter Ellen V Director | Grant | 364 | $0.00 | $0 |
| 2026-06-10 | Carlton Pamela G Director | Grant | 364 | $0.00 | $0 |
| 2026-03-06 | Williamson Sarah K Director | Open-market buy | 2,000 | $290.43 | $581k |
| 2026-02-19 | Weinberg John S CEO/Chairman | Grant | 31,528 | $0.00 | $0 |
| 2026-02-19 | Pensa Paul Contr, Prin. Acct.Officer | Grant | 1,867 | $0.00 | $0 |
| 2026-02-19 | Lindsey-Clark Matthew Co-Head EMEA IB | Grant | 7,638 | $0.00 | $0 |
| 2026-02-19 | Lalonde Timothy Gilbert Chief Financial Officer | Grant | 12,465 | $0.00 | $0 |
| 2026-02-19 | Klurfeld Jason General Counsel | Grant | 8,799 | $0.00 | $0 |
| 2026-02-19 | Altman Roger C Founder and Senior Chairman | Grant | 30,062 | $0.00 | $0 |
| 2026-02-13 | Klurfeld Jason General Counsel | Tax withholding | 374 | $328.56 | $123k |
| 2026-02-06 | 2 co-filers General Counsel | Open-market sale | 5,000 | $360.00 | $1.8m |
| 2026-02-05 | 2 co-filers Contr, Prin. Acct.Officer | Open-market sale | 1,450 | $350.31 | $508k |
| 2026-02-04 | Altman Roger C Founder and Senior Chairman | Tax withholding | 13,554 | $346.23 | $4.7m |
| 2026-02-04 | 2 co-filers General Counsel | Tax withholding | 5,319 | $346.23 | $1.8m |
| 2026-02-04 | 2 co-filers Contr, Prin. Acct.Officer | Tax withholding | 1,255 | $346.23 | $435k |
| 2026-02-04 | Lindsey-Clark Matthew Co-Head EMEA IB | Tax withholding | 3,578 | $346.23 | $1.2m |
| 2026-02-04 | Weinberg John S CEO/Chairman | Tax withholding | 13,360 | $346.23 | $4.6m |
| 2026-02-04 | Lalonde Timothy Gilbert Chief Financial Officer | Tax withholding | 7,320 | $346.23 | $2.5m |
| 2025-12-31 | 2 co-filers Chief Financial Officer | Option exercise | 100,000 | $0.00 | — |
| 2025-12-31 | 2 co-filers Chief Financial Officer | Option exercise | 150,000 | $0.00 | — |
| 2025-12-09 | Carlton Pamela G Director | Open-market sale | 192 | $343.11 | $66k |
| 2025-11-06 | Altman Roger C Founder and Senior Chairman | Gift | 33,400 | — | — |
EOD close · as of 2026-10-29
Where each multiple sits in its own 14-yr range · 72th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 14-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
ROE 29% against ROIC 29% — 0% of the return on equity comes from leverage and buybacks rather than from the operating business.
Equity is the year-end figure. On average equity over the two year-ends, ROE is 31.7% — the two diverge when buybacks or issuance move equity during the year.
What the company owes vs. what it holds
This shows debt/cash structure and net leverage. The year-by-year maturity schedule is on the Debt & Leverage tab.
Latest year: profit growth vs revenue growth
Operating leverage needs meaningful revenue change.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Income Tax | 5.2 | 4.7 | 5.6 | 7.5 | 6.2 | 3.3 | 3.9 | 3.9 |
| Net Income | 18.1 | 14.7 | 15.3 | 22.4 | 17.2 | 10.4 | 12.6 | 15.3 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on EVR: price, valuation and headline fundamentals from SEC filings. The four questions at the top of the page are where the judgements live.
No positive operating income in the last three years, so there is no return on capital to compare against its cost.
| Fiscal year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY2016 | not reported | not reported | 7.4% |
| FY2017 | not reported | not reported | 7.3% |
| FY2018 | not reported | not reported | 18.1% |
| FY2019 | not reported | not reported | 14.7% |
| FY2020 | not reported | not reported | 15.3% |
| FY2021 | not reported | not reported | 22.4% |
| FY2022 | not reported | not reported | 17.1% |
| FY2023 | not reported | not reported | 10.5% |
| FY2024 | not reported | not reported | 12.6% |
| FY2025 | not reported | not reported | 15.3% |
Return on equity (29%) and return on invested capital (29%) are within a couple of points in FY2025, so the headline return is the operating return — there is no meaningful leverage effect to strip out.
No material counter-signal in the checked set: ROIC vs WACC spread, 5-year spread history, gross margin trend, operating margin trend, net margin against 3 years ago, revenue growth, ROIC ex-goodwill gap.
Missing from our data, so excluded from this answer: positive EBIT.
Cash conversion is 1.83x but SBC is 17.4% of revenue.
Cash conversion is strong at 1.83x, but SBC is 17.4% of revenue — the cash flow looks clean partly because paying people in stock never passes through it.
Debt is present but there is no positive EBITDA or no reported interest expense, so coverage cannot be measured.
Balance sheet at 2025-12-31. Undrawn revolving credit is not shown: the tag is collected but not yet mapped through to the API.
No material counter-signal in the checked set: net debt / EBITDA, interest coverage, stressed coverage, maturity schedule vs cash and one year of FCF, liquidity ratios.
Missing from our data, so excluded from this answer: ebitda.
At $297.59, free cash flow must compound 21.83%/yr for 10 years. It has done 37.97%/yr over 6 years after stock compensation.
| Fiscal year | FCF growth | Price requires |
|---|---|---|
| FY2020 | 658.2% | 21.8% |
| FY2021 | 67.6% | 21.8% |
| FY2022 | −95.6% | 21.8% |
| FY2023 | −289.7% | 21.8% |
| FY2025 | 30.7% | 21.8% |
The percentile ranks the FISCAL-YEAR point, because the distribution behind each strip is built from fiscal-year closes — ranking a TTM figure inside it would compare two different bases. TTM basis: TTM (share count from the last fiscal year — the TTM window reports none).
This is solved on free cash flow AFTER stock compensation ($273M against $859M before it). On the unadjusted figure the requirement would be 5.19%/yr. Which is right depends on whether you think the share issuance is a recurring cost of running the business.
| Step | Amount | Running total |
|---|---|---|
| Net income | $592M | $592M |
| Share-based comp | $675M | $1.27B |
| Other non-cash & working capital | −$11M | $1.26B |
| Operating cash flow | $1.26B | $1.26B |
| Capex | −$74M | $1.18B |
| Free cash flow | $1.18B | $1.18B |
| FCF after SBC | $507M | $507M |
| Fiscal year | Revenue growth | Receivables growth | Gap |
|---|---|---|---|
| FY2020 | 12.6% | 24.3% | 11.6 points |
| FY2021 | 44.7% | -4.5% | -49.2 points |
| FY2022 | -16.0% | 9.5% | 25.5 points |
| FY2023 | -12.1% | -3.5% | 8.6 points |
| FY2024 | 22.7% | 13.4% | -9.2 points |
| FY2025 | 29.5% | 31.9% | 2.4 points |
| Fiscal year | DSO | DIO | DPO | Cash conversion cycle |
|---|---|---|---|---|
| FY2019 | 53.3 days | not reported | not reported | not reported |
| FY2020 | 58.8 days | not reported | not reported | not reported |
| FY2021 | 38.8 days | not reported | not reported | not reported |
| FY2022 | 50.6 days | not reported | not reported | not reported |
| FY2023 | 55.5 days | not reported | not reported | not reported |
| FY2024 | 51.3 days | not reported | not reported | not reported |
| FY2025 | 52.3 days | not reported | not reported | not reported |
| Fiscal year | Accruals / assets |
|---|---|
| FY2019 | -8.0 percent |
| FY2020 | -18.6 percent |
| FY2021 | -17.0 percent |
| FY2022 | -1.5 percent |
| FY2023 | -5.5 percent |
| FY2024 | -14.6 percent |
| FY2025 | -12.4 percent |
Below the line, the asset base is being consumed faster than it is replaced.
Depreciation here includes amortisation of acquired intangibles — goodwill written down over time, customer lists, acquired technology. Capex does not replace those and is not meant to, so an acquisitive or asset-light company sits below 1.0 permanently and correctly. The signal is cleanest for capital-intensive businesses, where the two measure the same physical base. For that reason this informs the earnings-quality verdict but never caps it.
SBC is added back inside operating cash flow, so reported free cash flow treats shares issued to employees as free. Percent of revenue says how expensive the payroll is; percent of operating cash flow says how much of the cash exists only because the charge was added back. The buyback offset is buybacks over SBC — below 1.0 the repurchase does not cover the shares issued.
Figures are the latest fiscal year (FY2025) from the company's own filings, not a trailing-twelve-month window — Q2 reads fiscal years throughout so the cash-conversion ratios and these share one basis. A blank is a line the filer did not report; it is never read as zero.